James P. De Andrade

Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas

Maria V. Bogachek, Jung M. Park, James P. De Andrade et al. · Stem Cell Reports · 2016 · 70 citations · Full text

Sarcopenia is a risk factor for complications and an independent predictor of hospital length of stay in trauma patients

James P. De Andrade, Mark Pedersen, Luis J. García et al. · Journal of Surgical Research · 2017 · 59 citations

Traumatology, Independent Predictor, Patient Safety +11

Inhibition of RET Increases the Efficacy of Antiestrogen and Is a Novel Treatment Strategy for Luminal Breast Cancer

Philip M. Spanheimer, Jung Min Park, Ryan W. Askeland et al. · Clinical Cancer Research · 2014 · 47 citations · Full text

EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib

James P. De Andrade, Jung M. Park, Vivian W. Gu et al. · Molecular Cancer Therapeutics · 2016 · 36 citations · Full text

Breast Oncology, Oncology, Egfr Is +15

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Philip M. Spanheimer, Allison W. Lorenzen, James P. De Andrade et al. · Annals of Surgical Oncology · 2015 · 29 citations · Full text

Breast Oncology, Medicine, Receptor Tyrosine Kinase +8